suuntautuminen kaava Hai resistant tb treatment Samaa mieltä vaha apu
39 Management of drug resistant Tuberculosis Session 01 - YouTube
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea - Respiratory Medicine
Groups of drugs to treat MDR-TB taken from the Treatment of... | Download Table
Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola in: The American Journal of Tropical Medicine and Hygiene Volume 101 Issue 3 (2019)
PLOS ONE: Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment - ScienceDirect
Efficacy and effect of free treatment on multidrug‑resistant tuberculosis
Tuberculosis treatment: one-shot approach or cascade of regimens? - The Lancet Respiratory Medicine
Multidrug-resistant tuberculosis (MDR-TB)
Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013 - Clinical Microbiology and Infection
New guide launched for nurses to manage Drug-Resistant Tuberculosis side effects | ICN - International Council of Nurses
Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management Prasad R, Singh A, Balasubramanian V, Gupta N - Indian J Med Res
Figure 1 from Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR- TB) Patients to Diagnostic and Treatment Services in Cambodia | Semantic Scholar
Delamanid for Extensively Drug-Resistant Tuberculosis | NEJM
Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study - Clinical Microbiology and Infection
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control
Multidrug-resistant tuberculosis
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases
10.3 Building a treatment regimen for MDR-TB - Tuberculosis
XDR-TB treatment outcomes. | Download Table
Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia | Scientific Reports
Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management Prasad R, Gupta N, Banka A - Lung India
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements - Respiratory Medicine
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis - The Lancet Infectious Diseases
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease
Exploring the Threat of MDR-TB in the United States
WHO's Rapid Communication on Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis